AUPH
Ticker
Aurinia Pharmaceuticals Inc.
AUPH · Healthcare · Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with h…Aurinia Pharmaceuticals Inc. (AUPH), in the Healthcare sector, has 4 disclosed filings on Paydirt over the trailing twelve months from 2 corporate insiders: 2 purchases and 2 sales. Filers took a median of 4 days from execution to disclosure, and the most recent trade was executed Sep 10 and filed Sep 11. The most active filer was Kevin Tang with 5 filings.
Add to watchlistFilings, ttm
4
2 buys · 2 sells
Traders, ttm
2
2 insiders
Volume, ttmiDollar value disclosed in the window
$25.6M
estimated for Congress, as filed for insiders
Median delay
4d
execution to disclosure
Last traded
Sep 10
Filed Sep 11
ADViAverage daily dollar volume
$22.3M
market data
Share price · 12M
$16.96 (+29.8%)
Adjusted for splits and dividends.
Volume by month
Buys $62.2M
Sells $6.5M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
KTRecent filings
Stephen P. RobertsonSALE
Chief Legal Officer
$190K11,939 sh × $15.95
Exec Sep 10
Filed Sep 11 · 4:26 PM ET Stephen P. RobertsonSALE Chief Legal Officer $356K
20,975 sh × $16.97
Exec Aug 21
Filed Aug 25 · 9:29 PM ET Kevin TangPURCHASE Chief Executive Officer $12.4M
812,208 sh across 3 lots
Exec May 29
Filed Jun 2 · 9:54 PM ET Kevin TangPURCHASE Director $12.7M
898,400 sh across 5 lots
Exec Feb 27
Filed Mar 3 · 5:35 PM ET Kevin TangPURCHASE Director $13.6M
1,300,000 sh across 3 lots
Exec Aug 1 2025
Filed Aug 5 2025 · 5:31 PM ET Greg KeenanSALE Chief Medical Officer $210K
20,000 sh × $10.50
Exec Aug 1 2025
Filed Aug 5 2025 · 5:30 PM ET Matthew Maxwell DonleySALE Chief Operating Officer $994K
124,893 sh across 2 lots
Exec Mar 3 2025
Filed Mar 4 2025 · 5:30 PM ET Stephen P. RobertsonSALE EVP, General Counsel $975K
122,479 sh across 2 lots
Exec Mar 3 2025
Filed Mar 4 2025 · 5:30 PM ET Joseph M MillerSALE Chief Financial Officer $940K
118,013 sh across 2 lots
Exec Mar 3 2025
Filed Mar 4 2025 · 5:30 PM ET Peter GreenleafSALE Chief Executive Officer $2.9M
360,540 sh across 2 lots
Exec Mar 3 2025
Filed Mar 4 2025 · 5:30 PM ET Kevin TangPURCHASE Director $12.7M
1,600,000 sh across 6 lots
Exec Feb 28 2025
Filed Mar 4 2025 · 5:30 PM ET Kevin TangPURCHASE Director $10.8M
1,200,000 sh across 3 lots
Exec Dec 5 2024
Filed Dec 9 2024 · 5:30 PM ET